Nexus Bio
↗Sydney, Australia
Nexus Bio (Nexus Biosciences) is an Australian-based life sciences company specializing in the distribution and consultancy of advanced biotechnology research tools and medical technologies. The company serves the Australia and New Zealand markets, providing researchers and clinicians with access to cutting-edge platforms in spatial biology, single-cell analysis, and cell therapy manufacturing.
Nexus Bio operates as a strategic partner for global technology providers, offering local expertise in market entry, regulatory navigation, and technical support. The company is deeply integrated into the Australian biotech ecosystem, with leadership involved in major accelerators such as the UNSW Health 10x program.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Life Sciences Distribution and Consultancy
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Self-funded / Private
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A - Service/Technology Provider
Modalities:Spatial Biology, Single-cell Proteomics, Cell Therapy Manufacturing, Flow Cytometry
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Akoya Biosciences (Spatial Biology), IsoPlexis (Single-cell Proteomics), Standard BioTools / Fluidigm, UNSW Health 10x Accelerator
COMPETITION
Position:Niche Player
Competitors:Millennium Science, Bio-Strategy, Abacus dx, Jomar Life Research
LEADERSHIP
Key Executives:
Guillaume Herry - Managing Director
Scientific Founders:Guillaume Herry
LINKS
Website:nexusbio.com.au
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Nexus Bio. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.